申请人:Shionogi & Co., Ltd.
公开号:US03932384A1
公开(公告)日:1976-01-13
Dibenzazecines of the general formula: ##SPC1## (wherein R.sup.1 and R.sup.2 are the same or different, each representing a hydrogen atom, a hydroxy group, a lower alkoxy group, an aralkoxy group, or a hydroxymethyl group; or when adjacent to and taken together with each other, they can be an alkylenedioxy group; R.sup.3, R.sup.4, and R.sup.5 are the same or different, each representing a hydrogen atom, a hydroxy group, or a lower alkoxy group, or two of them, when adjacent and bound to each other, they can be an alkylenedioxy group; and R.sup.6 represents a hydrogen atom, an alkyl group, and R.sup.6 represents a hydrogen atom, an alkyl group, an alkenyl group, an aralkyl group or a cycloalkyl group) or acid addition salts thereof, exhibiting CNS depressant actions such as analgesic action, sedative action, and so on; which can be produced from the dibenzoquinolizines.
通式为:##SPC1## 的二苯并氮杂环化合物(其中R1和R2相同或不同,分别表示氢原子,羟基,低级烷氧基,芳基烷氧基或羟甲基基团;或者相邻并结合在一起时,它们可以是烷二氧基基团;R3,R4和R5相同或不同,分别表示氢原子,羟基或低级烷氧基,或者当相邻并结合在一起时,它们可以是烷二氧基基团;R6表示氢原子,烷基,R6表示氢原子,烷基,烯基,芳基烷基或环烷基)或其酸加成盐,具有中枢神经系统抑制作用,如镇痛作用,镇静作用等;可以从二苯并喹啉制备而来。